[
    {
        "title": "1.",
        "body": "Incubate aliquots of 100 μl LPS or LTA which is resuspended in 0.01 M pH 7.4 PBS in a 96-well microtitre plate \\(Maxisorp®, NUNC, Denmark) at room temperature overnight."
    },
    {
        "title": "2.",
        "body": "Rinse the wells three times with 300 μl of PBS each."
    },
    {
        "title": "3.",
        "body": "Block the wells with 150 μl of PBS with 2% \\(w/v) BSA at 37 °C for 2 h."
    },
    {
        "title": "4.",
        "body": "Rinse the wells three times with 300 μl of PBS each."
    },
    {
        "title": "5.",
        "body": [
            "Add to each well, 100 μl of the serially diluted protein \\(HMC or Hb in 2% BSA) in PBST \\(PBS containing 0.05% v/v Tween",
            {
                "title": "20)",
                "body": "and incubate at 37°C for 1 h."
            }
        ]
    },
    {
        "title": "6.",
        "body": "Rinse the wells three times with 300 μl of PBST each."
    },
    {
        "title": "7.",
        "body": "Add to each well, 100 μl of primary antibody \\(rabbit-anti HMC or rabbit-anti Hb), which is diluted to 1:500 with 2% BSA in PBST and further incubate at 37 °C for 30 min."
    },
    {
        "title": "8.",
        "body": "Rinse the wells three times with 300 μl of PBST each."
    },
    {
        "title": "9.",
        "body": "Add to each well, 100 μl of the horseradish peroxidase-conjugated goat-anti-rabbit antibody \\(DAKO, Japan), which is diluted to 1:1000 in 2% BSA in PBST, and incubate at 37 °C for 30 min."
    },
    {
        "title": "10.",
        "body": "Rinse the wells three times with 300 μl of PBST each."
    },
    {
        "title": "11.",
        "body": "Immediately before using, dissolve peroxidase substrate tablet \\(ABTS, 2,2’-azino-bis\\[3-ethylbenzthiazoline-6-sulfonic acid], Roche) in substrate solution \\(Roche) as indicated by the manufacturer’s manual."
    },
    {
        "title": "12.",
        "body": "Add to each well, 50 μl of the peroxidase substrate and incubate for 10 min at room temperature."
    },
    {
        "title": "13.",
        "body": "Read the OD at 405 nm."
    },
    {
        "title": "14.",
        "body": [
            "To verify the specificity of the protein-PAMP interaction observed in the ELISA, further examine whether or not pre-incubation of HMC or Hb with LPS or LTA could reduce the ELISA-readout in a dose-dependent manner.",
            {
                "title": "a)",
                "body": "Choose a concentration of either HMC or Hb that shows an ELISA-readout\\(A405)at the linear range."
            },
            {
                "title": "b)",
                "body": "Incubate the HMC or Hb with 0-200 μg/ml LPS or LTA in 2% BSA in PBST at 37 °C for 1 h."
            },
            {
                "title": "c)",
                "body": "Then transfer the reaction mixture to the LPS- or LTA- immobilized microtitre plate."
            },
            {
                "title": "d)",
                "body": "Conduct the ELISA as described in steps 5-13."
            },
            {
                "title": "e)",
                "body": "The reduction of the readout of HMC or Hb pre-incubated with LPS or LTA respectively, demonstrates the specificity of the protein-PAMP interaction."
            }
        ]
    }
]